NYSE$MPT

Medical Properties Trust Inc · Q1 2025 earnings

Q1 2025 earnings · · Before market open · Investor relations

Briefing

Medical Properties Trust reported Q1 2025 total revenues of $223.8M with a net loss of $118.3M and diluted EPS of $(0.20).

Total revenues were $223.8 million as rent and financing income continued. The net loss attributable to common shareholders was $118.3 million, or $0.20 per diluted share, driven by real-estate impairments and fair-value adjustments.

  • Q1 total revenues $223.8M.
  • Net loss $118.3M; impairments $76.1M.
  • Hospital tenant transitions and asset sales.
  • Liquidity and balance-sheet repositioning.

Headline financials

Total Revenue

$224M

Previous: $271M-17.5%
EPS (adj)

-$0.20

Previous: -$1.46+86.3%
Total Gross Assets

$16.4B

No prior period
Adjusted Net Debt to Annualized EBITDAre Ratio

9.9

No prior period
Financial Leverage

58.8%

No prior period
Adjusted Interest Coverage Ratio

1.9

No prior period
Capital Expenditures

-$39.3M

Previous: -$72.9M+46.1%
Net Income

-$118M

Previous: -$876M+86.5%
Operating Income

-$5.3M

Previous: -$461M+98.8%

Revenue & EPS history

Medical Properties Trust · Revenue · Quarterly

$224M

Q1 2025-17.5%vs Q1 2024
Beat estimate in 6 of 14 quarters(43%)
ActualEstimate

Revenue by segment

Medical Properties Trust · $307M total across 4 segments · Q3 2023

  • Rent Billed
    $229M-1.3%
  • Interest and Other Income
    $29.7M-29.9%
  • Income from Financing Leases
    $26.1M-48.9%
  • Straight-line Rent
    $21.5M-19.0%

Forward guidance

Management discusses operating priorities, capital allocation, and sector risks in the quarterly filing.

Tailwinds

  • Headline results and segment trends anchor the quarter.
  • Liquidity and balance-sheet capacity support operations.
  • Strategic initiatives outlined in MD&A.

Headwinds

  • Macro, rates, or input costs may pressure margins.
  • One-time items affect year-over-year comparability.
  • Execution risk on growth or restructuring plans.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2025

Historical avgQ1 2025

+1.3%

Avg return

Earnings day

+1.6%

Avg return

5 days after

+0.7%

Avg return

30 days after

65%

42 / 65 earnings

Positive

+17.0%

Q4 2024

Best reaction

-15.8%

Q2 2023

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.6%-4.1%-6.0%
Q4 2025+12.1%+6.1%-15.1%
Q3 2025+6.6%+1.4%+18.5%
Q1 2025-6.9%-8.0%-17.2%
Q4 2024+17.0%+18.2%+26.6%
Q3 2024+7.0%-5.2%-9.8%
Q2 2024+1.5%+2.4%+7.4%
Q1 2024+7.2%+31.2%+20.4%
Q4 2023+2.5%+6.7%+13.9%
Q3 2023+9.9%+7.2%+4.7%
Q2 2023-15.8%-20.0%-33.4%
Q1 2023+10.6%+4.9%-0.1%
Q4 2022-13.5%-15.6%-38.3%
Q3 2022+6.8%+6.5%+20.6%
Q2 2022-5.3%-4.3%-15.3%
Q1 2022+4.1%+6.3%+5.2%
Q4 2021-4.0%-5.2%-10.2%
Q3 2021+0.1%-1.2%+1.5%
Q2 2021+1.3%-1.5%-3.3%
Q1 2021-2.0%-4.1%-5.9%
Q4 2020+0.0%+1.6%-2.9%
Q3 2020+3.7%+10.9%+13.8%
Q2 2020-0.8%-1.6%-8.5%
Q1 2020+4.1%+0.5%+9.8%
Q4 2019+2.3%+3.6%+1.1%
Q3 2019+1.2%-6.8%+0.9%
Q2 2019+2.1%-0.1%+6.2%
Q1 2019+3.8%+1.2%+2.0%
Q4 2018+3.4%+1.7%+1.1%
Q3 2018+3.2%+9.9%+16.2%
Q2 2018+1.0%+3.0%+4.2%
Q1 2018+1.8%+2.0%+5.6%
Q4 2017+1.6%+1.5%+6.6%
Q3 2017+3.2%+3.9%+4.8%
Q2 2017-1.7%+0.1%+5.2%
Q1 2017+2.1%+2.5%+4.3%
Q4 2016+1.8%+1.8%-6.3%
Q3 2016-0.8%+1.3%-2.7%
Q2 2016+1.1%+2.0%-0.5%
Q1 2016+3.8%
Q4 2015-2.5%
Q3 2015-3.4%
Q2 2015-3.8%
Q1 2015+2.9%
Q4 2014+0.4%
Q3 2014+2.7%
Q2 2014-0.3%
Q1 2014-0.9%
Q4 2013-0.4%
Q3 2013-0.7%
Q2 2013-2.8%
Q1 2013-1.0%
Q4 2012+1.1%
Q3 2012+3.1%
Q2 2012+0.7%
Q1 2012-0.1%
Q4 2011-0.6%
Q4 2009-0.6%
Q3 2011-4.4%
Q2 2011+4.5%
Q1 2011+2.8%
Q4 2010+2.8%
Q3 2010+0.5%
Q2 2010+1.0%
Q1 2010+7.9%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro